Dr. Maryam Tabatabai is the vice president of clinical information at Magellan Rx Management. She provides dynamic oversight and actively engages in drug and clinical information, evidence-based writing, development of clinical policies, as well as specialty and traditional drug pipeline forecasting. Dr. Tabatabai provides thought leadership and targeted insights for a wide range of audiences on the most impactful trends in the pharmacy and healthcare spheres. She leads drug recall efforts and steers the supply chain task force. She is a champion of raising awareness and providing trusted education to patients and other key stakeholders on COVID-19 vaccines and therapeutics. Dr. Tabatabai is the editor-in-chief for several Magellan Rx Management clinical publications, including MRx Pipeline, Clinical Alert, and Trend Alert blog. Since obtaining her Doctor of Pharmacy degree, she has gained meaningful pharmacy and clinical experience in the community, academic, hospital, and ambulatory care settings. Upon completing her pharmacy practice residency, she joined Magellan where she has been a central and respected clinical resource across the enterprise.
